Skip to content

Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis

Predictors of Survival for Complete Clinical Responders to Definite Chemoradiation or Radiation Therapy for Esophageal Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01525953
Acronym
CRCRT-EC
Enrollment
110
Registered
2012-02-03
Start date
2012-01-31
Completion date
2012-01-31
Last updated
2012-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Keywords

esophageal cancer, radiochemotherapy, prognosis

Brief summary

The aim of this study is to identify prognostic factors for outcome in patients being complete clinical responders with chemoradiation or radiation for esophageal cancer

Interventions

DRUGChemotherapy

Chemotherapy according to standard

RADIATIONRadiotherapy

Radiotherapy according to local standard

Sponsors

Centre Oscar Lambret
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* localized or locally advanced esophageal cancer * patient who underwent definite chemoradiation or radiation * patient with complete clinical response

Exclusion criteria

* metastatic disease

Design outcomes

Primary

MeasureTime frameDescription
Identification of prognostic factors for overall survivalFrom date of treatment until death, assessed up to 10 yearsCorrelation between survival and baseline,clinical and treatment characteristics

Secondary

MeasureTime frameDescription
Patterns of treatment failureFrom date of treatment until treatment failure, assessed up to 10 yearsType of recurrence : local, regional, distant.
Disease-free survivalFrom date of treatment until progression or death, assessed up to 10 yearsTime between the end of treatment and the occurence of progression

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026